Cargando…
Liquid biopsy on the horizon in immunotherapy of non-small cell lung cancer: current status, challenges, and perspectives
Non-small cell lung cancer (NSCLC) is one of the most threatening malignancies to human health and life. In most cases, patients with NSCLC are already at an advanced stage when they are diagnosed. In recent years, lung cancer has made great progress in precision therapy, but the efficacy of immunot...
Autores principales: | Yang, Ying, Liu, Hongyang, Chen, Youming, Xiao, Nan, Zheng, Zhaoyang, Liu, Hongchun, Wan, Junhu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10066332/ https://www.ncbi.nlm.nih.gov/pubmed/37002211 http://dx.doi.org/10.1038/s41419-023-05757-5 |
Ejemplares similares
-
Liquid Biopsy: Current Status and Future Perspectives
por: Baev, Vesselin, et al.
Publicado: (2023) -
Liquid biopsy in cholangiocarcinoma: Current status and future perspectives
por: Rompianesi, Gianluca, et al.
Publicado: (2021) -
Current status and future perspectives of liquid biopsy in non-small cell lung cancer
por: Chang, Sunhee, et al.
Publicado: (2020) -
Current Status and Future Perspectives of Liquid Biopsy in Small Cell Lung Cancer
por: Mondelo-Macía, Patricia, et al.
Publicado: (2021) -
Liquid Biopsy in Prostate Cancer Management—Current Challenges and Future Perspectives
por: Crocetto, Felice, et al.
Publicado: (2022)